Analysis of γ-Aminobutyric Acid (GABA) Type A Receptor Subtypes Using Isosteric and Allosteric Ligands
- 12 July 2014
- journal article
- Published by Springer Nature in Neurochemical Research
- Vol. 39 (10) , 1924-1941
Abstract
The GABAA receptors (GABAARs) play an important role in inhibitory transmission in the brain. The GABAARs could be identified using a medicinal chemistry approach to characterize with a series of chemical structural analogues, some identified in nature, some synthesized, to control the structural conformational rigidity/flexibility so as to define the ‘receptor-specific’ GABA agonist ligand structure. In addition to the isosteric site ligands, these ligand-gated chloride ion channel proteins exhibited modulation by several chemotypes of allosteric ligands, that help define structure and function. The channel blocker picrotoxin identified a noncompetitive channel blocker site in GABAARs. This ligand site is located in the transmembrane channel pore, whereas the GABA agonist site is in the extracellular domain at subunit interfaces, a site useful for low energy coupled conformational changes of the functional channel domain. Also in the trans-membrane domain are allosteric modulatory ligand sites, mostly positive, for diverse chemotypes with general anesthetic efficacy, namely, the volatile and intravenous agents: barbiturates, etomidate, propofol, long-chain alcohols, and neurosteroids. The last are apparent endogenous positive allosteric modulators of GABAARs. These binding sites depend on the GABAAR heteropentameric subunit composition, i.e., subtypes. Two classes of pharmacologically very important allosteric modulatory ligand binding site reside in the extracellular domain at modified agonist sites at other subunit interfaces: the benzodiazepine site, and the low-dose ethanol site. The benzodiazepine site is specific for certain subunit combination subtypes, mainly synaptically localized. In contrast, the low-dose (high affinity) ethanol site(s) is found at a modified benzodiazepine site on different, extrasynaptic, subtypes.Keywords
This publication has 181 references indexed in Scilit:
- Mixed antagonistic effects of the ginkgolides at recombinant human ρ1 GABAC receptorsNeuropharmacology, 2012
- Knockout of the γ-aminobutyric acid receptor subunit α4 reduces functional δ-containing extrasynaptic receptors in hippocampal pyramidal cells at the onset of pubertyBrain Research, 2012
- Diazepam-bound GABAA receptor models identify new benzodiazepine binding-site ligandsNature Chemical Biology, 2012
- Principles of activation and permeation in an anion-selective Cys-loop receptorNature, 2011
- New insights into the GABAA receptor structure and orthosteric ligand binding: Receptor modeling guided by experimental dataProteins: Structure, Function, and Bioinformatics, 2011
- The role of GABAA receptors in the acute and chronic effects of ethanol: a decade of progressPsychopharmacology, 2009
- Physiology and pharmacology of alcohol: the imidazobenzodiazepine alcohol antagonist site on subtypes of GABAAreceptors as an opportunity for drug development?British Journal of Pharmacology, 2008
- α1β2δ, a silent GABAAreceptor: recruitment by tracazolate and neurosteroidsBritish Journal of Pharmacology, 2008
- Ethanol acts directly on extrasynaptic subtypes of GABAA receptors to increase tonic inhibitionAlcohol, 2007
- Low dose acute alcohol effects on GABAA receptor subtypesPharmacology & Therapeutics, 2006